What “Brineura” patent are people usually referring to?
Brineura is the brand name for cerliponase alfa, an enzyme replacement therapy used to treat CLN2 (neuronal ceroid lipofuscinosis type 2). Searches for “Brineura patent” typically aim at one of these:
- When Brineura’s key patents expire (or when exclusivity ends)
- Whether biosimilar/alternative versions could launch before then
- Which companies hold the patents and what they cover (drug substance, formulations, methods of use)
Patent timelines for a biologic drug are usually driven by a mix of “patents” and separate regulatory exclusivities, which can differ by country.
When does Brineura’s patent expire?
I can’t answer the expiration date from the information provided. Brineura’s relevant expiry depends on jurisdiction (for example, US vs EU), the specific patent family, and whether you’re asking about patent expiration or regulatory exclusivity.
How do biosimilars work for Brineura before patent expiry?
Because Brineura is a biologic, competing products typically do not launch until the earliest of:
- Patent protection covering the product (including methods of use)
- Regulatory exclusivity protections
Even if a manufacturer is able to start clinical work or submit regulatory packages, commercial launch generally waits until the relevant legal barriers clear.
Where can I find the exact Brineura patent(s)?
To identify the exact Brineura patents (and their expiration dates), the most direct sources are patent/regulatory databases for the target country, for example:
- US: FDA’s biologics listings plus the Orange Book/Biologics guidance links and associated patent registries
- EU: national patent registers and EMA-linked regulatory protection records
If you tell me the country (US, EU, UK, etc.) and whether you mean “earliest launch date,” “the main drug patent,” or “methods of use,” I can narrow down what to look for and how to interpret the timelines.
Are there patent disputes or challenges tied to Brineura?
I can’t confirm any specific Brineura litigation or challenges without the underlying sources you want used. If you share a case caption, company name, or a link, I can help explain what the patents cover and what the dispute changes for timing.
Quick questions to pinpoint what you need
1) Which jurisdiction: US, EU, UK, or another country?
2) Do you want the date for the “first” patent to expire, or the last one blocking launch?
3) Are you looking for patents held on the drug itself, the formulation/dosing, or the clinical method of use?
Sources
No sources were provided with your question, so none could be cited.